Skip to content

Opening book details…

Can I read Acyldepsipeptide Antibiotics and a Bioactive Fragment Thereof Differentially Perturb Mycobacterium tuberculosis ClpXP1P2 Activity in Vitro on EtoBox?

Acyldepsipeptide Antibiotics and a Bioactive Fragment Thereof Differentially Perturb Mycobacterium tuberculosis ClpXP1P2 Activity in Vitro by Schmitz, Karl R.; Handy, Emma L.; Compton, Corey L.; Gupta, Shashank; Bishai, William R.; Sauer, Robert T.; Sello, Jason K. is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Acyldepsipeptide Antibiotics and a Bioactive Fragment Thereof Differentially Perturb Mycobacterium tuberculosis ClpXP1P2 Activity in Vitro about?

Proteolytic complexes in Mycobacterium tuberculosis (Mtb), the deadliest bacterial pathogen, are major foci in tuberculosis drug development programs. The Clp proteases, which are essential for Mtb viability, are high priority targets. These proteases function through the collaboration of ClpP1P2, a barrel-shaped heteromeric peptidase, with associated ATP-dependent chaperones like ClpX and ClpC1 that recognize and unfold specific substrates in an ATP-dependent fashion. The critical interaction of the peptidase and its unfoldase partners is blocked by the competitive binding of acyldepsipeptide antibiotics (ADEPs) to the interfaces of the ClpP2 subunits. The resulting inhibition of Clp protease activity is lethal to Mtb. Here, we report the surprising discovery that a fragment of the ADEPs retains anti-Mtb activity, yet stimulates rather than inhibits the ClpXP1P2-catalyzed degradation of proteins. Our data further suggest that the fragment stabilizes the ClpXP1P2 complex and binds ClpP1P2 in a fashion distinct from the intact ADEPs. A structure-activity relationship study of the bioactive fragment defines the pharmacophore and points the way towards the development of new drug lead

Who reads Acyldepsipeptide Antibiotics and a Bioactive Fragment Thereof Differentially Perturb Mycobacterium tuberculosis ClpXP1P2 Activity in Vitro?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Schmitz, Karl R.; Handy, Emma L.; Compton, Corey L.; Gupta, Shashank; Bishai, William R.; Sauer, Robert T.; Sello, Jason K.
Publisher
American Chemical Society; American Chemical Society (ACS) (ISSN 1554-8929)
Published
2020
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Schmitz, Karl R.; Handy, Emma L.; Compton, Corey L.; Gupta, Shashank; Bishai, William R.; Sauer, Robert T.; Sello, Jason K.

Browse all works by Schmitz, Karl R.; Handy, Emma L.; Compton, Corey L.; Gupta, Shashank; Bishai, William R.; Sauer, Robert T.; Sello, Jason K.